Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Colorcon
Citi
McKesson
Deloitte
UBS
Healthtrust
Chubb
Queensland Health

Generated: September 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020410

« Back to Dashboard

NDA 020410 describes GASTROMARK, which is a drug marketed by Amag Pharms Inc and is included in one NDA. Additional details are available on the GASTROMARK profile page.

The generic ingredient in GASTROMARK is ferumoxsil. There is one drug master file entry for this compound. Additional details are available on the ferumoxsil profile page.
Summary for 020410
Tradename:GASTROMARK
Applicant:Amag Pharms Inc
Ingredient:ferumoxsil
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION;ORALStrengthEQ 0.175MG IRON/ML
Approval Date:Dec 6, 1996TE:RLD:No

Expired US Patents for NDA 020410

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Amag Pharms Inc GASTROMARK ferumoxsil SUSPENSION;ORAL 020410-001 Dec 6, 1996 ➤ Sign Up ➤ Sign Up
Amag Pharms Inc GASTROMARK ferumoxsil SUSPENSION;ORAL 020410-001 Dec 6, 1996 ➤ Sign Up ➤ Sign Up
Amag Pharms Inc GASTROMARK ferumoxsil SUSPENSION;ORAL 020410-001 Dec 6, 1996 ➤ Sign Up ➤ Sign Up
Amag Pharms Inc GASTROMARK ferumoxsil SUSPENSION;ORAL 020410-001 Dec 6, 1996 ➤ Sign Up ➤ Sign Up
Amag Pharms Inc GASTROMARK ferumoxsil SUSPENSION;ORAL 020410-001 Dec 6, 1996 ➤ Sign Up ➤ Sign Up
Amag Pharms Inc GASTROMARK ferumoxsil SUSPENSION;ORAL 020410-001 Dec 6, 1996 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Argus Health
Fuji
AstraZeneca
QuintilesIMS
Express Scripts
Accenture
Deloitte
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.